Literature DB >> 9614556

The levels of integrin alpha v beta 5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells.

K Takayama1, H Ueno, X H Pei, Y Nakanishi, J Yatsunami, N Hara.   

Abstract

Adenovirus mediated transfer of growth-inhibiting molecules, such as p53 shows promise as an effective method of suppressing the growth of cancer cells. As the basis for in vivo studies, we examined transfection efficiency using 15 human lung cancer cell lines that differ in their endogenous p53 status. When infected with an adenovirus expressing bacterial beta-galactosidase, the different cell lines showed different levels of beta-galactosidase activity. We found a correlation between the level of integrin alpha v beta 5, which is thought to be an adherence receptor for adenoviruses, and the expression level of the transferred gene, suggesting that gene expression is largely dependent on the infection efficiency. Growth inhibition was induced in all cell lines tested following infection with an adenovirus containing p53, regardless of the genetic status of their endogenous p53 provided a sufficient amount of p53 protein was expressed. Our results (1) confirm that the examination of the susceptibility of target cancer cells to an adenovirus is important when considering performing adenovirus-mediated gene transfer and for evaluating its therapeutic effects; and (2) suggest that the quantification of integrin alpha v beta 5 may be a good way of predicting the susceptibility of cells to adenoviral vectors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614556     DOI: 10.1038/sj.gt.3300608

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  12 in total

1.  CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts.

Authors:  C Hidaka; E Milano; P L Leopold; J M Bergelson; N R Hackett; R W Finberg; T J Wickham; I Kovesdi; P Roelvink; R G Crystal
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

2.  Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer model.

Authors:  Lena J Gamble; Hideyo Ugai; Minghui Wang; Anton V Borovjagin; Qiana L Matthews
Journal:  J Mol Biochem       Date:  2012-02-15

3.  Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review).

Authors:  Lena J Gamble; Anton V Borovjagin; Qiana L Matthews
Journal:  Exp Ther Med       Date:  2010-03       Impact factor: 2.447

4.  Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoprotein.

Authors:  C Brimer; J T Dalton; Z Zhu; J Schuetz; K Yasuda; E Vanin; M V Relling; Y Lu; E G Schuetz
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

5.  Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application.

Authors:  K Takayama; P N Reynolds; Y Adachi; L Kaliberova; J Uchino; Y Nakanishi; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-10-06       Impact factor: 5.987

6.  Role of genetic susceptibility to latent adenoviral infection and decreased lung function.

Authors:  Ikuma Kasuga; James C Hogg; Peter D Paré; Shizu Hayashi; Edward G Sedgwick; Jian Ruan; Alison M Wallace; Jian-Qing He; Xiaozhu Zhang; Andrew J Sandford
Journal:  Respir Med       Date:  2009-06-06       Impact factor: 3.415

7.  Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas.

Authors:  N Shinoura; S Sakurai; F Shibasaki; A Asai; T Kirino; H Hamada
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

8.  iTRAQ-Based and Label-Free Proteomics Approaches for Studies of Human Adenovirus Infections.

Authors:  Hung V Trinh; Jonas Grossmann; Peter Gehrig; Bernd Roschitzki; Ralph Schlapbach; Urs F Greber; Silvio Hemmi
Journal:  Int J Proteomics       Date:  2013-03-11

9.  Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress.

Authors:  Carlos Farkas; Carla P Martins; David Escobar; Matias I Hepp; Ariel F Castro; Gerard Evan; José L Gutiérrez; Robert Warren; David B Donner; Roxana Pincheira
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

Review 10.  Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancer.

Authors:  Julia Reetz; Ottmar Herchenröder; Brigitte M Pützer
Journal:  Viruses       Date:  2014-04-02       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.